Thomas K. Equels - 30 Nov 2023 Form 4 Insider Report for AIM ImmunoTech Inc. (AIM)

Role
CEO & President, Director
Signature
/s/ Thomas K Equels
Issuer symbol
AIM
Transactions as of
30 Nov 2023
Net transactions value
$0
Form type
4
Filing time
27 Mar 2024, 13:52:24 UTC
Previous filing
27 Nov 2023
Next filing
18 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AIM Options Award $0 +300,000 $0.000000 300,000 30 Nov 2023 Common Stock 300,000 $0.4700 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.